Grace Auld
Queen Square
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mild-to-moderate depressive symptoms impact on self-reported outcome measures in clinical trials for neurodegenerative diseases.
Journal: Clinical trials (London, England)
Published: December 01, 2025
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: October 07, 2024
Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early- to Mid-Stage Parkinson's Disease Modification Trials.
Journal: Movement disorders clinical practice
Published: April 10, 2024
The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability.
Journal: Drugs & aging
Published: March 11, 2021
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.
Journal: Brain : a journal of neurology
Published: April 27, 2020
Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.
Journal: Nature medicine
Published: November 20, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026